Hip circumference
Hip circumference has been studied in 7 papers since 2017: 6 observational studies in people, 1 review; 1 in the past year. The newest paper, Feb 28, 2026: “Evaluating the association of anthropometric indices and their principal components with type 2 diabetes in a cross-sectional study”.
7 papers study it3 findingsUpdated
See all 7 papers on hip circumference
At a glance
The findings reach people, from one lab or study. 2 independent labs in 2 countries.
“HC was inversely associated with dementia both in females (HRQ4 vs. Q1 = 0.75; 95% CI: 0.64, 0.86; P-trend < 0.001)”
None of its findings points the other way.
- 2 independent labs in 2 countries
- Funders: National Science and Technology Council and 1 more
- Humans6
What did studies of hip circumference find?
1Studies of hip circumference measured one outcome, cognitive function.
Cognitive function
no changein humans1
1 study
Cognitive function
no changein humans1
Hip circumference was not clearly linked with cognitive function in humans.
“HC and general obesity (defined by BMI and BFP) were not significantly associated with cognitive performance.”
Humans
BMC geriatrics
What is hip circumference linked with?
2Studies link hip circumference with 2 measures: dementia and Parkinson's disease.
Dementia
downin humans1
1 study
Dementia
downin humans1
Hip circumference is linked with a lower risk of dementia in humans (highest vs lowest quartile, mutually adjusted for waist circumference) (HR Q4 vs Q1 0.75 (95% CI 0.64–0.86)).
“HC was inversely associated with dementia both in females (HRQ4 vs. Q1 = 0.75; 95% CI: 0.64, 0.86; P-trend < 0.001)”
Humanshighest vs lowest quartile, mutually adjusted for waist circumferencemedian 12.7 yearsfemales
Association of Android and Gynoid Fatness With Incident Dementia and Brain Structure
Journal of cachexia, sarcopenia and muscle
Parkinson's disease
downin silico1OR 0.83
1 study
Parkinson's disease
downin silico1OR 0.83
Hip circumference lowers the risk of Parkinson's disease in silico (OR: 0.83).
“higher measures of body fatness are associated with a decreased risk of PD, including BMI (OR: 0.83), body fat percentage (OR: 0.69), body fat mass (OR: 0.77), and hip circumference (OR: 0.83).”
In silico
Novel Insights Into the Causal Effects and Shared Genetics Between Body Fat and Parkinson Disease
CNS neuroscience & therapeutics